The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

Major pharmacy-benefit managers generated $7.3 billion in markups on specialty drugs from pharmacies they are affiliated with ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...

At issue is the role pharmacy benefit mangers play in taking large discounts on drugs that advocates say are not passed along ...

A key provision in the new legislation could affect compensation for brokers or consultants who help employers hire pharmacy ...